Can AI Improve IVF Success Rates? Let's find out

India's IVF Chain of the Year — four consecutive years — took the India AI Impact Summit stage in February 2026 to show what happens when reproductive medicine meets machine learning. The answer isn't theoretical.

For most of IVF's clinical history, treatment decisions have been made through a combination of protocol, experience, and educated guesswork. Every patient is different. Hormonal responses vary. Optimal medication dosages are not consistent across bodies. The "standard protocol" for one patient may be dangerously wrong for another. And fertility specialists, for all their expertise, are working with imperfect information under significant emotional and clinical pressure.

This is precisely the problem that Dr. Gunjan Gupta Govil — Founder and Medical Director of Gunjan IVF World — set out to reframe. With over 24 years in reproductive medicine and a network of IVF clinics across Delhi, Ghaziabad, Meerut, and Noida, she has seen what the average fertility journey costs patients: financially, physically, and emotionally. Her thesis is simple and radical: AI can reduce the uncertainty, and fewer uncertain decisions mean better outcomes for more families.

On February 17, 2026, at the India AI Impact Summit at Bharat Mandapam in New Delhi, Dr. Gunjan Gupta Govil took the stage for a session titled "AI in Healthcare: Navigating Innovation, Ethics, and Regulatory Compliance." She wasn't there to discuss concepts. She demonstrated two working AI tools: an AI-Based Fertility Meter for patient assessment and data-driven fertility evaluation, and an AI-Based HMG Dosage Calculator designed to optimise medication dosages through intelligent data analysis. Both tools were built from the clinical patterns accumulated over decades of practice — and both were live products in use.

Gunjan IVF World has been awarded India's IVF Chain of the Year — North region — for four consecutive years: 2023, 2024, 2025, and 2026. The recognition comes from the Economic Times Health awards, one of the most credible healthcare sector rankings in India. It's not a participation trophy. Winning four years in a row in a sector that is growing as rapidly as Indian fertility care signals something structural about how the organisation operates.

In fertility treatment, every failed cycle is a data point that tells you something about the patient's biology. The clinics that learn faster from that data — and adjust their protocols accordingly — will consistently outperform those that don't.

The Scale of India's Fertility Problem — And the Technology Gap

India has an enormous and underserved fertility challenge. Approximately 27.5 million couples in India experience infertility. IVF cycles have grown significantly in the country over the last decade, but access remains heavily concentrated in urban centres, quality is highly variable, and the cost of multiple failed cycles is both financially and psychologically devastating for most families.

The fundamental tension is this: IVF outcomes improve with data and protocol personalisation, but data accumulation requires volume, and volume requires infrastructure. Large fertility chains like Gunjan IVF World accumulate the clinical data that small independent clinics never can. The AI tools they're developing turn that data advantage into a clinical advantage — and, eventually, a patient outcomes advantage.

80%+Take-home baby rate at Gunjan IVF World

25,000+Successful deliveries at the chain

4 yrsConsecutive IVF Chain of Year (ET Health, North)

24+ yrsDr. Gunjan Gupta Govil's clinical experience

The AI Fertility Meter: What It Actually Does

The AI-Based Fertility Meter is not a diagnostic replacement for a clinician — it's a patient assessment tool designed to enhance pre-treatment evaluation. It processes patient data across multiple parameters — hormonal markers, reproductive history, age, physical indicators — and generates a personalised fertility assessment that helps clinicians stratify patients by their likely response to different treatment protocols.

The clinical value is in reducing protocol guesswork at the earliest stage of treatment. By providing a data-driven fertility assessment before the first injection is administered, the tool helps doctors have more informed conversations with patients about realistic expectations and appropriate treatment pathways. That matters enormously in a clinical context where managing patient expectations is as important as managing their medication.

The HMG Dosage Calculator: Precision Where Precision Matters Most

Gonadotropin dosage during ovarian stimulation is one of the most consequential decisions in IVF. Too low, and the response is inadequate — the cycle fails or is converted. Too high, and the patient risks ovarian hyperstimulation syndrome (OHSS), a potentially serious complication. The "correct" dose is highly individual, and determining it has traditionally relied heavily on clinician experience and sequential monitoring.

The AI-Based HMG Dosage Calculator attempts to bring computational precision to this decision. By processing patient-specific data — prior response history, baseline hormonal levels, age, weight, diagnostic category — the tool generates dosage recommendations that are personalised rather than protocol-based. The claimed benefit is fewer cycle cancellations, reduced OHSS risk, and improved outcomes across the patient population.

AI Application in IVFGunjan IVF World's ApproachClinical ImpactCurrent MaturityPatient stratificationAI Fertility Meter — pre-treatment assessmentBetter protocol selection, expectation managementDeployed, in active clinical useDosage optimisationAI HMG Dosage CalculatorReduced OHSS risk, improved stimulation outcomesDeployed, clinician-assisted decisionsEmbryo selectionNot yet announcedHigher implantation rates (competitor space)Global research stage, not deployed herePredictive analyticsTreatment pathway optimisationEvidence-based personalisation at scaleIn development based on 25K+ delivery data

The Data Moat: 25,000+ Deliveries as a Competitive Asset

AI tools in healthcare are only as good as the data they're trained on. Gunjan IVF World's most significant competitive asset isn't its technology — it's the 25,000+ deliveries and corresponding clinical data accumulated over more than two decades of fertility practice. That dataset, combined with Dr. Gupta Govil's clinical pattern recognition, forms the ground truth on which the AI tools are built.

No newly-founded fertility tech startup can replicate this from scratch. The clinical data advantage that large, experienced chains have over new entrants is enormous — and it's the kind of moat that compounds rather than erodes. More patients → more data → better AI → better outcomes → more referrals → more patients. Gunjan IVF World is several steps into that loop.

Risks & Blind Spots

• Regulatory pathway for AI medical devices: India's CDSCO regulatory framework for AI-based medical tools is still evolving. Tools used in clinical decision-making need clear regulatory classification — and the pathway for AI-augmented fertility tools is still being defined.

• Outcome claims require clinical validation: The 80% take-home baby rate and the claims around AI tool efficacy require transparent, peer-reviewed clinical data to be fully credible to the broader medical community. Individual outcome claims at a single chain are promising but not generalisable without rigorous study design.

• AI in high-stakes medicine is held to a different standard: A wrong recommendation from an HMG calculator could harm a patient. The liability framework for AI-assisted clinical decisions in India is not clearly established, which creates both institutional and clinical risk.

• Chain expansion vs. quality maintenance: Gunjan IVF World's Delhi, Ghaziabad, Meerut, and Noida presence is significant. Expanding the chain further while maintaining the clinical quality that drives the award wins requires careful governance.

• Proprietary vs. open AI: Building proprietary clinical AI tools rather than integrating best-in-class global solutions is a high-cost choice. The bet is that proprietary India-specific clinical data generates superior tools — which may be true for Indian patient populations but limits benchmarking against global standards.

Frequently Asked Questions

What is Gunjan IVF World and who founded it?

Gunjan IVF World is a leading IVF and fertility treatment chain operating across Delhi, Ghaziabad, Meerut, and Noida in the National Capital Region. It was founded and is led by Dr. Gunjan Gupta Govil, a reproductive medicine specialist with over 24 years of clinical experience. The chain has been named IVF Chain of the Year (North India) by ET Health for four consecutive years: 2023, 2024, 2025, and 2026.

What AI tools has Gunjan IVF World developed?

Gunjan IVF World has developed two AI-based clinical tools: an AI-Based Fertility Meter for patient assessment and data-driven fertility evaluation, and an AI-Based HMG Dosage Calculator designed to optimise medication dosages during ovarian stimulation. Both were demonstrated at the India AI Impact Summit 2026 in February 2026.

What is the success rate at Gunjan IVF World?

Gunjan IVF World reports an 80%+ take-home baby rate across its clinic network, with over 25,000 successful deliveries achieved since inception. These figures are reported by the clinic and should be evaluated alongside standard IVF success rate methodology — age group, cycle type, and patient selection all significantly affect outcomes across any fertility centre.

How does AI improve IVF outcomes specifically?

AI can improve IVF outcomes by enabling personalised treatment protocols rather than one-size-fits-all approaches. Key applications include patient stratification (matching treatment protocol to individual biology), dosage optimisation (reducing under- or over-stimulation), and predictive analytics (identifying patients at risk of poor response before treatment begins). Each reduces the number of failed cycles and improves the likelihood of a successful pregnancy within a given number of attempts.

Is Gunjan IVF World available for consultations outside the NCR?

Gunjan IVF World's physical clinics are located in Delhi, Ghaziabad, Meerut, and Noida. Dr. Gunjan Gupta Govil is available for consultations at these centres. The organisation may also provide tele-consultation options for initial patient assessments. For current availability and appointment options, contact via the official website is recommended.

The Verdict

Gunjan IVF World is not just a fertility clinic chain that has won some awards — it is an organisation actively building the infrastructure for data-driven reproductive medicine at a scale that most Indian fertility providers have not attempted. The India AI Impact Summit presentation in February 2026 wasn't a brand exercise; it was a public commitment to an AI strategy that the clinical team is already executing.

The data moat is real. Twenty-five thousand deliveries, 24 years of clinical practice, and the pattern recognition that comes from seeing what works and what doesn't across thousands of individual patient journeys — that is genuinely hard to replicate. The AI tools built on top of that data have a foundation that first-generation fertility tech startups simply cannot match.

The clinical ethics and regulatory questions are legitimate and unresolved. But the directional bet — that AI-assisted fertility care will systematically outperform protocol-based fertility care for individualised patients — is correct. Gunjan IVF World is building toward that future from a position of clinical credibility that gives it every reason to succeed.

India's IVF Chain of the Year is now building the AI infrastructure for the next generation of fertility care.

Sources & References

Gunjan IVF World — AI Innovation at India AI Impact Summit 2026  ·  gunjanivfworld.com  ·  ET Health IVF Chain of the Year award citations 2023–2026  ·  India AI Impact Summit 2026, Government of India, Bharat Mandapam (Feb 17, 2026)

This article was prepared for editorial and informational purposes. All figures cited are drawn from publicly available company statements and press coverage.

For more important updates and curated information on regular basis, Join our whatsapp community : https://chat.whatsapp.com/DfkQi7r4o4dDduWvYor9dk